On January 30, 2023 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that Robert E. Hoffman, President and CEO of Kintara, will be presenting at the BIO CEO & Investor Conference on Monday, February 6, 2023 (Press release, Kintara Therapeutics, JAN 30, 2023, View Source [SID1234626637]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Hoffman’s presentation will highlight the recent Company developments on its novel therapies for hard to treat cancers, ongoing pipeline progress, clinical trial updates, and anticipated milestones. Details about the presentation are as follows:

Presenter: Robert E. Hoffman, President and CEO of Kintara
Date: Monday, February 6, 2023, at 4:30 p.m. EST
Location: Marriott Marquis, New York, NY
Registration: Here

In its 25th year, BIO CEO is one of the largest investor conferences in the life science industry. Kintara will be available for in person and virtual partnering meetings. Those interested in scheduling a meeting may do so through the BIO One-on-One Partnering system: View Source